Up Therapeutics
PrivateTotal Funding Raised
$2.5M
Company Overview
Up Therapeutics is a biotechnology company that develops small molecule Rpn13 inhibitors for the treatment of various cancers, including solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
small molecule inhibitoroncology therapeuticsRPN13 inhibitordrug discoverysolid tumor treatmentbiotech startuppreclinical biotechproteasome inhibitordrug licensingcancer drug developmentfirst-in-class drugtherapeutic pipelinebiotech R&Ddrug candidate
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Up Therapeutics Comparables
Compare Up Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SHY Therapeutics | 82% | |
| QLi5 Therapeutics GmbH | 77% | |
| Ubiquigent Limited | 63% | |
Up Therapeutics Funding Rounds
Historical fundraising activity
Up Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| National Institutes of Health (NIH) | Grant |
Up Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Up Therapeutics's valuation, stock price, and market status.
See something wrong or outdated?